Rare diseases
Investigational molecules
Locations
Study on the Use of Alteplase and Andexanet Alfa for Patients with Acute Ischemic Stroke on Non-Vitamin K Oral Anticoagulants
PolandIntrapleural Alteplase and Dornase Alfa versus VATS for Patients with Pleural Empyema (Parapneumonic Pleural Infection)
The NetherlandsStudy of alteplase and tenecteplase for intravenous thrombolysis in patients with ischemic stroke who are taking direct oral anticoagulants
AustriaStudy on the Effectiveness of Tenecteplase in Patients with Acute Ischemic Stroke Taking Rivaroxaban, Apixaban, or Edoxaban
DenmarkStudy on Intra-Arterial Thrombolysis with Alteplase for Patients with Acute Ischemic Stroke in the Anterior Circulation
FranceStudy of Catheter-Directed Thrombolysis Using Alteplase for Treatment of Intermediate-High Risk Acute Pulmonary Embolism
CzechiaStudy on Tenecteplase and Alteplase for Patients with Acute Ischemic Stroke Due to Basilar Artery Blockage
FranceStudy Comparing Dornase Alfa and Alteplase with Surgery for Treating Pleural Empyema in Patients
DenmarkStudy on Vitrectomy, Alteplase, and Aflibercept for Patients with Wet Age-Related Macular Degeneration and Submacular Hemorrhage
GermanyStudy on the Safety and Effectiveness of Semaglutide for Non-Diabetic Patients with Acute Ischemic Stroke
DenmarkStudy on Treatments for Intermediate High-Risk Pulmonary Embolism: Comparing Percutaneous Embolectomy, Ultrasound-Assisted Thrombolysis with Alteplase, and Heparin
DenmarkReduced-dose versus full-dose alteplase for high-risk acute pulmonary embolism patients: a randomized multicenter trial
DenmarkTell us about your condition – we search every trial in Europe and connect you with the right site.
